Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorGALLERANI, E.
dc.contributor.authorPROIETTO, D.
dc.contributor.authorDALLAN, B.
dc.contributor.authorCAMPAGNARO, M.
dc.contributor.authorPACIFICO, S.
dc.contributor.authorALBANESE, V.
dc.contributor.authorMARZOLA, E.
dc.contributor.authorMARCONI, P.
dc.contributor.authorCAPUTO, A.
hal.structure.identifierImmunology from Concept and Experiments to Translation [ImmunoConcept]
dc.contributor.authorAPPAY, Victor
dc.contributor.authorGAVIOLI, R.
dc.contributor.authorNICOLI, F.
dc.date.accessioned2022-05-02T15:53:20Z
dc.date.available2022-05-02T15:53:20Z
dc.date.issued2021
dc.identifier.issn1664-3224en_US
dc.identifier.otherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.693054/ full#supplementary-materialen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/139959
dc.description.abstractEnAdvanced age is associated with severe symptoms and death upon SARS-CoV-2 infection. Virus-specific CD8+ T-cell responses have shown to be protective toward critical COVID-19 manifestations, suggesting that suboptimal cellular immunity may contribute to the age-pattern of the disease. The induction of a CD8+ T-cell response against an emerging pathogen like SARS-CoV-2 relies on the activation of naive T cells. To investigate whether the primary CD8+ T-cell response against this virus is defective in advanced age, we used an in vitro approach to prime SARS-CoV-2-specific naive CD8+ T cells from healthy, unexposed donors of different age groups. Compared to younger adults, older individuals display a poor SARS-CoV-2-specific T-cell priming capacity in terms of both magnitude and quality of the response. In addition, older subjects recognize a lower number of epitopes. Our results implicate that immune aging is associated with altered primary SARS-CoV-2-specific CD8+ T-cell responses.
dc.language.isoENen_US
dc.subject.enCD8+ T cells
dc.subject.enCellular immunity
dc.subject.enEpitopes
dc.subject.enImmune aging
dc.subject.enNaive T cells
dc.subject.enPrimary responses
dc.subject.enSARS-CoV-2
dc.title.enImpaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects
dc.typeArticle de revueen_US
dc.identifier.doi10.3389/fimmu.2021.693054en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
dc.identifier.pubmed34326844en_US
bordeaux.journalFrontiers in Immunologyen_US
bordeaux.volume12en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03657268
hal.version1
hal.date.transferred2022-05-02T15:53:21Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers%20in%20Immunology&rft.date=2021&rft.volume=12&rft.eissn=1664-3224&rft.issn=1664-3224&rft.au=GALLERANI,%20E.&PROIETTO,%20D.&DALLAN,%20B.&CAMPAGNARO,%20M.&PACIFICO,%20S.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée